India vs Indonesia: Average cost of drugs for extensively drug-resistant tuberculosis
India
1,203 constant 2022 US$
in 2024
Indonesia
1,138 constant 2022 US$
in 2024
India rank
39th
Indonesia rank
40th
Average cost of drugs for extensively drug-resistant tuberculosis over time
- India
- Indonesia
How they compare
India currently reports 1,203 constant 2022 US$ against 1,138 constant 2022 US$ in Indonesia, a difference of 65 constant 2022 US$.
That makes India's figure about 1.1 times Indonesia's.
The two have swapped places 2 times across 5 shared years of data; in 2020 it was India ahead.
India ranks 39th and Indonesia ranks 40th of 56 countries.
India has averaged higher in every one of the 1 decades both report.
Frequently asked questions
- Which has higher average cost of drugs for extensively drug-resistant tuberculosis, India or Indonesia?
- India, at 1,203 constant 2022 US$ against 1,138 constant 2022 US$ in Indonesia as of 2024.
- What is the difference in average cost of drugs for extensively drug-resistant tuberculosis between India and Indonesia?
- 65 constant 2022 US$, with India ahead.
- How many years of comparable data are there for India and Indonesia?
- 5 years are reported by both, from 2020 to 2024.
- How do India and Indonesia rank globally for average cost of drugs for extensively drug-resistant tuberculosis?
- India ranks 39th and Indonesia ranks 40th of 56 countries.
- Where does this data come from?
- WHO (2025) – with minor processing by Our World in Data, published as Average cost of drugs for extensively drug-resistant tuberculosis. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Average cost of drugs spent per patient starting extensively drug-resistant tuberculosis treatment, excluding buffer stock.